News
FDA Requires Doctors to Advise Patients about ESA Risks and Benefits
2/19/2010
NAAC
The U.S. Food and Drug Administration (FDA) announced that they will soon require medical professionals prescribing erythropoiesis-stimulating agents (ESAs) to provide a Medication Guide to patients and to formally educate them about...Click here to learn more.